On the determination of the time delay in reaching the steady state drug concentration in the organ compared to plasma

被引:10
作者
Berezhkovskiy, Leonid M. [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
关键词
time of reaching the steady state in plasma and tissue; terminal volume of distribution; steady state volume of distribution; terminal half-life; kinetics of drug; distribution into tissue; brain distribution kinetics; in-vivo based pharmacokinetic model; linear pharmacokinetics;
D O I
10.1002/jps.20986
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A problem of substantial delay in reaching the steady state drug concentration in particular organ (compartment) compared to the time of reaching the steady state plasma concentration is considered. It is shown that the ratio of the terminal (V-beta) and the steady state (V-ss) volumes of distribution, V-beta/V-ss, appears to be an indication of possible lag in reaching the steady state in the organ tissue compared to plasma. The estimations of the time of reaching the steady state drug concentration in the organ are suggested. The in-vivo based pharmacokinetic model, which uses the experimentally measured drug plasma concentration time course and the appropriate equation for the kinetics of drug distribution into the tissues, is suggested. It is intended to determine the kinetic mechanism of drug distribution into the tissues. The model was applied to interpret the kinetics of drug distribution into the brain. The importance of precise measurement of drug plasma concentration at terminal phase for obtaining accurate values of V-beta and V-ss is emphasized: this allows predicting a possible slow plasma-tissue drug transfer and substantial difference in time of reaching the steady state by the body and plasma. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:3432 / 3443
页数:12
相关论文
共 15 条
[1]   The connection between the steady state (Vss) and terminal (Vβ) volumes of distribution in linear pharmacokinetics and the general proof that Vβ≥Vss [J].
Berezhkovskiy, Leonid M. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (06) :1638-1652
[2]   The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics: The traditional equation may considerably overestimate the true value [J].
Berezhkovskiy, LM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (04) :834-848
[3]   Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination [J].
Berezhkovskiy, LM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (06) :1628-1640
[4]  
CHEYMOL G, 1995, BRIT J CLIN PHARMACO, V39, P684
[5]   Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy [J].
Christensen, JD ;
Yurgelun-Todd, DA ;
Babb, SM ;
Gruber, SA ;
Cohen, BM ;
Renshaw, PF .
BRAIN RESEARCH, 1999, 834 (1-2) :1-5
[6]   Pharmacokinetic-pharmacodynamic modelling: History and perspectives [J].
Csajka, Chantal ;
Verotta, Davide .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2006, 33 (03) :227-279
[7]   LINEAR-SYSTEMS ANALYSIS IN PHARMACOKINETICS [J].
CUTLER, DJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (03) :265-282
[8]   Two components of blood-brain barrier disruption in the rat [J].
Easton, AS ;
Sarker, MH ;
Fraser, PA .
JOURNAL OF PHYSIOLOGY-LONDON, 1997, 503 (03) :613-623
[9]   Zidovudine concentration in brain extracellular fluid measured by microdialysis: Steady-state and transient results in rhesus monkey [J].
Fox, E ;
Bungay, PM ;
Bacher, J ;
McCully, CL ;
Dedrick, RL ;
Balis, FM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (03) :1003-1011
[10]   FACTORS AFFECTING DRUG METABOLISM [J].
GILLETTE, JR .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :43-&